These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


721 related items for PubMed ID: 9534323

  • 1. [The influence of ACE inhibitors on urinary electrolyte secretion and the response to transitory hypovolemia in chronic heart failure].
    Marenzi G, Lauri G, Assanelli E, Grazi M, Guazzi M, Berna G, Salvioni A, Agostoni P.
    Cardiologia; 1997 Dec; 42(12):1277-83. PubMed ID: 9534323
    [Abstract] [Full Text] [Related]

  • 2. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA.
    Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046
    [Abstract] [Full Text] [Related]

  • 3. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs.
    Watkins L, Burton JA, Haber E, Cant JR, Smith FW, Barger AC.
    J Clin Invest; 1976 Jun 26; 57(6):1606-17. PubMed ID: 180056
    [Abstract] [Full Text] [Related]

  • 4. [Interrelation of plasma volume, fluid metabolism and neurohormonal activation after ultrafiltration in congestive heart failure].
    Marenzi G, Agostoni PG, Lauri G, Perego GB, Grazi M, Schianni M, Giraldi F, Salvioni A, Guazzi M.
    Cardiologia; 1992 Dec 26; 37(12):831-7. PubMed ID: 1363883
    [Abstract] [Full Text] [Related]

  • 5. [Inhibition of the neurohumoral axis after intravascular fluid depletion in congestive heart failure with water retention: mechanisms of the perpetuation of the syndrome].
    Marenzi G, Lauri G, Guazzi M, Perego GB, Matturri M, Salvioni A, Giraldi F, Agostoni PG.
    Cardiologia; 1995 Jan 26; 40(1):15-22. PubMed ID: 8529234
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K.
    Am J Vet Res; 1996 Nov 26; 57(11):1645-52. PubMed ID: 8915446
    [Abstract] [Full Text] [Related]

  • 7. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E, Perez-Villa F, Morales M, Jiménez W, Orús J, Heras M, Sanz G.
    Eur Heart J; 2000 Jan 26; 21(1):53-7. PubMed ID: 10610744
    [Abstract] [Full Text] [Related]

  • 8. [Neurohumoral activation, regulation of sodium excretion and vasodilator treatment in heart insufficiency].
    Pimenta J, Pereira M, Castro A, Dias P, Azevedo A, Bettencourt P, Ferreira A.
    Rev Port Cardiol; 2002 Feb 26; 21(2):157-62. PubMed ID: 11963285
    [Abstract] [Full Text] [Related]

  • 9. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul 26; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 10. Aldosterone and renin-angiotensin responses to stimuli in patients with treated congestive heart failure.
    Nicholls MG, Espiner EA, Donald RA.
    J Lab Clin Med; 1976 Jun 26; 87(6):1005-15. PubMed ID: 180213
    [Abstract] [Full Text] [Related]

  • 11. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A, Bettencourt P, Dias P, Pestana M, Serrão P, Soares-da-Silva P, Cerqueira-Gomes M.
    Clin Sci (Lond); 2001 May 26; 100(5):557-66. PubMed ID: 11294697
    [Abstract] [Full Text] [Related]

  • 12. [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
    Marenzi G, Guazzi M, Lauri G, Perego GB, Sganzerla P, Agostoni P.
    Cardiologia; 1994 Nov 26; 39(11):763-72. PubMed ID: 7736475
    [Abstract] [Full Text] [Related]

  • 13. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 26; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 14. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L, Shore AC, Mott V, Wilkinson R.
    Q J Med; 1985 Aug 26; 56(220):485-96. PubMed ID: 3901077
    [Abstract] [Full Text] [Related]

  • 15. [Atrial natriuretic factor in patients with cardiac decompensation before and after chronic therapy with an angiotensin-converting enzyme inhibitor].
    Pomini G, Rugna A, Lupia M, Opocher G, Gribaldo R.
    G Ital Cardiol; 1992 Jul 26; 22(7):807-12. PubMed ID: 1473654
    [Abstract] [Full Text] [Related]

  • 16. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Clin Sci (Lond); 2002 Jun 26; 102(6):653-60. PubMed ID: 12049620
    [Abstract] [Full Text] [Related]

  • 17. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
    Dieterich HA, Wendt C, Saborowski F.
    Fiziol Cheloveka; 2005 Jun 26; 31(6):97-105. PubMed ID: 16366159
    [Abstract] [Full Text] [Related]

  • 18. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan 26; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 19. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure.
    Packer M, Kukin ML, Neuberg GW, Pinsky DJ, Penn J, Abittan MH.
    J Hypertens Suppl; 1989 Sep 26; 7(5):S33-6. PubMed ID: 2681605
    [Abstract] [Full Text] [Related]

  • 20. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP, Vittorio TJ, Dimayuga CA, Homma S, Rizkala A, Le Jemtel TH, Katz SD.
    Am J Cardiol; 2004 Dec 15; 94(12):1501-5. PubMed ID: 15589004
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.